-
Wall Street advances as traders' bets rise for bigger Fed rate cut
By Sinéad Carew and Shashwat Chauhan (Reuters) -Wall Street's main indexes closed higher on Friday as investors honed in on the chance of a bigger interest rate cut by the Federal Reserve... More
-
- Moderna shares slip premarket as analysts cut ratings amid guidance worries
- The former NY Fed chief Dudley sees a strong case for a 50bp rate cut - report
- Oil eases on resuming US output after storm, rising rig count
- US dollar drops to near 9-month low versus yen amid talk of larger Fed rate cut
- US regulator orders Wells Fargo to overhaul its efforts to combat illicit funds
- This stock is a 'rare durable sports/entertainment asset' says Pivotal
- AAII sentiment survey: pessimism rises
- 5 takeaways from Moderna's investor day
- Norfolk Southern CEO Shaw replaced by CFO over alleged affair with legal head
- Uber jumps on extended partnership with Google's Waymo
- Citi restarts coverage of Eli Lilly with Buy rating on increased tirzepatide forecasts
- Couche-Tard weighs increasing offer for Japan’s Seven&I- Bloomberg
- Microstrategy (MSTR) acquires a further $1.11B in bitcoins
- This energy stock is a new Top Pick at Morgan Stanley
- China e-commerce shares fall on report Biden to curb low-value shipments
-
-
Prospect of steeper Fed cuts boosts stocks, drives record gold prices
By Pete Schroeder (Reuters) -U.S. stocks advanced on Friday and gold continued to hit record highs as investors looked to whether the Federal Reserve might move more aggressively to cut rates at... More
-
Fed faces dilemma over 25 or 50 bps cut in Sept, WSJ’s Timiraos says
Investing.com-- The Federal Reserve faces a dilemma over cutting interest rates when it meets next week, the Wall Street Journals Nick Timiraos said, as the decision comes amid a cooling labor market and... More
-
Adobe forecasts downbeat quarterly earnings on cautious tech spending
(Reuters) - Photoshop maker Adobe forecast fourth-quarter earnings below analysts' estimates on Thursday, signaling stiff competition and soft demand for its AI-integrated editing tools amid challenging economic conditions. Shares of the company fell 9.2%... More
-
Oracle shares rise further to record high on bumper AI-fueled forecast
Investing.com-- Shares of Oracle Corporation (NYSE: ORCL) surged in aftermarket trade on Thursday, pushing further into record-high territory after the cloud computing firm flagged strong revenue growth in... More
Sunday, September 15, 2024 6:57 AM EDT
To See the Full Feed, Get StreetInsider Premium Today
Latest StreetInsider Headlines
- 06:05 AM
- 05:53 AM
- 03:11 AM
- 03:10 AM
- 03:00 AM
- 03:00 AM MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
- 03:00 AM 23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study
- 03:00 AM 23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial
- 02:30 AM New data from TAR-200 Phase 2b SunRISe-1 study show 84 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer
- 12:12 AM Lewis Access Proudly Introduces its New Range of Premium Access Solutions - Made in the UK
To See the Full Feed, Get StreetInsider Premium Today
13Fs
- Chubb Corp. (CB) Climbs After Berkshire's 13F Shows Stake
- Buffett's Berkshire adds Atlanta Braves stocks, sells GM and Procter & Gamble
- Starboard Value raises stake in Acacia Research, exits Splunk and Papa John's
Accesswire
- Best Gold IRA Companies in the US 2024 Rankings Announced
- Gold IRA vs Physical Gold: Key Differences Explained by an Expert
- TCL Launches the C655 PRO QLED TV: Elevating Home Entertainment With Advanced Features and Superior Performance
Analyst Comments
- Chow Tai Fook Jewellery Group Ltd. (1929:HK) (CJEWF) PT Lowered to HK$7.80 at UBS
- UBS Starts Laopu Gold (6181:HK) at Buy
- CLSA Downgrades KDX Realty Investment Corp (8972:JP) to Hold (3)
Analyst PT Change
- Chow Tai Fook Jewellery Group Ltd. (1929:HK) (CJEWF) PT Lowered to HK$7.80 at UBS
- Progressive Corp. (PGR) PT Raised to $280 at Keefe, Bruyette & Woods
- Oracle (ORCL) PT Raised to $172 at CFRA
Board Changes
- Snap (SNAP): Jim Lanzone Joins Board of Directors
- Volcon (VLCN) Announces Resignation Christian Okonsky from Board
- Polestar Automotive (PSNY) Announces Date of AGM and Board Changes
Business Wire
- First of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera's Ability to Predict Overall Survival
- Masimo Partners with Qualcomm to Develop Next-Generation Smartwatch Reference Platform for Original Equipment Manufacturers
- Cierto Tequila Wins Tequila of the Year at the 2024 Melbourne International Spirits Competition
Commodities
- Gold bulls set sights on previously dismissed record $3,000/oz milestone
- Oil prices rise, set for positive week amid rebound from 3-year lows
- Oil price rally steers crude towards weekly gain
Corporate News
- Drilling Tools International (DTI) Files for $250M Share Offering
- Manchester United plc (MANU) Files $400M Mixed Shelf
- General Dynamics NASSCO (GD) Receives Additional Eight-Ship Contract to Build T-AO 10-17
Cryptocurrency
- Microstrategy (MSTR) acquires a further $1.11B in bitcoins
- Microstrategy, Inc. (MSTR) acquires another $1.11B in bitcoins
- Crypto stocks drop after U.S. presidential debate
Dividends
- Equity Residential (EQR) Declares $0.675 Quarterly Dividend; 3.5% Yield
- Sylvamo (SLVM) Declares $0.45 Quarterly Dividend; 2.3% Yield
- Marvell Technology (MRVL) Declares $0.06 Quarterly Dividend; 0.3% Yield
Downgrades
- CLSA Downgrades KDX Realty Investment Corp (8972:JP) to Hold (3)
- Evercore ISI Downgrades Evercore Partners (EVR) to In Line
- Barclays Downgrades Revance Therapeutic (RVNC) to Equalweight
Earnings
- SelectQuote, Inc. (SLQT) Misses Q4 EPS by 2c, Offers Guidance
- Heart Test Laboratories, Inc. (HSCS) Tops Q2 EPS by 136c
- EVI Industries Inc. (EVI) Reports Q4 EPS of $0.14
Economic Data
- U of M 1 Yr Inflation (Sep P) 2.7% vs 2.8% Expected, 5-10 yr 3.1% vs 3%
- U of M Sentiment (Sep P ) 69 vs 68.5 Expected
- US import prices post largest drop in eight months
Equity Offerings
- Drilling Tools International (DTI) Files for $250M Share Offering
- Manchester United plc (MANU) Files $400M Mixed Shelf
- LQR House (LQR) Files $100M Mixed Shelf
FDA
- Eli Lilly & Co. (LLY) Announces FDA Approval of EBGLYSS for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis
- Halozyme Therapeutics (HALO) Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO with ENHANZE
- Regeneron (REGN): Dupixent Approved in U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Fed
- Goldman Sachs still sees 25 basis point Fed cut next week
- Wells Fargo Sees 25bps Easing by Fed next Week, 'we now expect the committee to launch this easing cycle with a tamer 25 bps cut'
- Evercore Sees 'Real Shot' of 50bps Easing by Fed Next Week, 'We believe a “dovish 25” does not really exist'
Globe Newswire
- Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging
- MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
- MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
Guidance
- Upwork Inc. (UPWK) Confirms Receipt and Comments on Shareholder Letter
- SelectQuote, Inc. (SLQT) Misses Q4 EPS by 2c, Offers Guidance
- Progressive (PGR) Reports August 2024 Results
Hedge Funds
- Engine Capital Pushes For New Board At Upwork (UPWK), Takes Stake - CNBC
- Point72 Plans To Return Some Cash To Investors For First Time - Bloomberg
- Elliott Statement on Southwest Airlines' (LUV) Board Resignations
Insiders' Blog
- 7 Things to Know About Allbirds' (BIRD) Upcoming $2 Billion IPO
- HireRight (HRT) IPO: 9 Things to Know About the Upcoming Offering
- Udemy (UDMY) IPO: 7 Things to Know About Upcoming $4 Billion IPO
IPOs
- Basel Medical Group (BMGL) Announces Proposed IPO
- Bicara Therapeutics (BCAX) Opens at $26.25 , Upsized IPO Priced at $18
- MBX Biosciences (MBX) Opens At $23, IPO Priced At $16
Market Check
- Futures slip on economic growth worries ahead of labor data
- U.S. stocks tumble as September starts, investors cool on chips
- S&P 500, Nasdaq Quickly Erase Gains
Mergers and Acquisitions
- Directv, Dish Said In Talks To Merge Satellite-TV Businesses - Bloomberg
- Upwork Inc. (UPWK) Confirms Receipt and Comments on Shareholder Letter
- Newpark Resources (NR) Announces Sale of Fluids Systems Segment
New Coverage
- UBS Starts Laopu Gold (6181:HK) at Buy
- Citi restarts coverage of Eli Lilly with Buy rating on increased tirzepatide forecasts
- Raymond James Starts Arm Holdings (ARM) at Outperform, 'Content Story in Early Innings'
Newsfile
- XinKailian Biotechnology Unveils GMP-Certified Ubiquinol with Patent Safety, Set for Debut at Vitafoods Asia 2024
- The 3rd International Summit for Mayors of Rural Tourism Villages & the Forum of Best Tourism Villages is Coming to Huangling, Wuyuan
- Introducing Printblur's 2024 Halloween-Inspired Product Lineup: Personalization, Diversity, and Global Presence
Press Releases
- Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging
- ESMO 2024 - ImmVira Unveils Clinical Results of Intravesical MVR-T3011 for High-Risk BCG-Failure NMIBC Patients
- Akeso Published First-Ever Efficacy Data for PD-1/VEGF Bispecific Antibody Ivonescimab with or without CD47 Antibody plus FOLFOXIRI for mCRC at ESMO 2024
Private Company News
- Coreweave Said In Talks For Share Sale At $23 Billion Valuation - Bloomberg
- OpenAI in talks to raise funds at $150 billion valuation, Bloomberg News reports
- OpenAI Said To Discuss Raising Funds At $150 Billion Valuation - Bloomberg
PRNewswire
- ESMO 2024 - ImmVira Unveils Clinical Results of Intravesical MVR-T3011 for High-Risk BCG-Failure NMIBC Patients
- Akeso Published First-Ever Efficacy Data for PD-1/VEGF Bispecific Antibody Ivonescimab with or without CD47 Antibody plus FOLFOXIRI for mCRC at ESMO 2024
- Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024
Reuters
- Two Spanish nationals arrested in Venezuela not linked to any plot to destabilise country, says Madrid
- Vietnam says 2024 GDP may decline 0.15% due to Typhoon Yagi's impact
- Eight die in Channel crossing attempt, French authorities say
SEC Filings
- Form 4 P3 Health Partners Inc. For: Sep 12 Filed by: CPF III PT SPV, LLC
- Form 4 OSI SYSTEMS INC For: Sep 13 Filed by: Morben Paul Keith
- Form SC 13D/A TKO Group Holdings, Inc. Filed by: Emanuel Ariel
SPAC
- Angel Studios to Become a Publicly Traded Company via Business Combination with Southport Acquisition Corporation (PORT)
- EEW Renewables and Compass Digital Acquisition Corp. (CDAQ) Announce Definitive Business Combination Agreement
- Medera to Go Public via Merger with Keen Vision Acquisition Corporation (KVAC)
